-
Wisconsin Supreme Court Decides Mesothelioma Claim in Favor of Independent Contractor
Earlier this month, the Wisconsin Supreme Court handed down a decision likely to have far-reaching repercussions for mesothelioma victims. The court decided that Pabst Brewing Company owed a duty of care to a union steamfitter who’d been exposed to asbestos on their premises, despite the man having been an independent contractor rather than the company’s
-
Daughters’ Motion to Exclude Collateral Payment Evidence from Mesothelioma Trial Granted
A Louisiana federal court has granted a request to keep evidence of collateral source payments out of a mesothelioma wrongful death case against Avondale Shipyard. The decision means that information about insurance, Social Security, Medicare, or other independent income received by the victim’s family is excluded from the trial.
-
Georgia-Pacific Plans New Filing to Resolve Mesothelioma Lawsuits
After nearly ten years of attempting the bankruptcy maneuver known as the “Texas Two-Step,” Georgia-Pacific appears to be moving toward a new bankruptcy filing to resolve tens of thousands of asbestos-related lawsuits, including claims filed by mesothelioma victims. The shift in strategy would put an end to one of the longest tests of the controversial
-
Researchers’ 3D Model Improves Mesothelioma Treatment Response Prediction
Researchers from Australia’s Asbestos and Dust Diseases Research Institute have developed 3D spheroid models of mesothelioma that accurately reflect how patients diagnosed with the rare, asbestos-related form of cancer respond to chemotherapy. The breakthrough provides more realistic testing platforms than traditional laboratory methods and could accelerate much-needed drug development.
-
Study Showing Safety of Lung Cancer Surgery for Patients 80+ May Apply to Mesothelioma
In a study that may have important implications for patients diagnosed with mesothelioma, researchers from Mount Sinai Hospital have found that adults aged 80 and older with early-stage lung cancer can safely undergo surgery and achieve outcomes comparable to younger patients. Though the two illnesses have important differences, similar surgical approaches and patient selection criteria
-
Family Files Mesothelioma Wrongful Death Lawsuit Against 14 Cosmetic Talc Companies
In February of 2025, Elaine S. Rose died of pleural mesothelioma at the young age of 63. One year later, her family members have named 14 different cosmetic and pharmaceutical companies as defendants in a wrongful death lawsuit filed in San Francisco Superior Court. Her survivors claim that her fatal asbestos-related cancer was a result
-
Australian Researchers Receive $500,000 Grant to Improve Mesothelioma Treatment
Professor Kieren Harvey from Peter MacCallum Cancer Centre in Victoria, Australia, has received a Worldwide Cancer Research Grant of more than $500,000 to study a promising new treatment for mesothelioma. Professor Harvey and his team will study a new class of drugs targeting the Hippo pathway, which plays a key role in controlling how cells
-
U.S. Senators Urge Supreme Court to Reject Bankruptcy Move in Mesothelioma Case
In recent years, multiple companies facing claims from mesothelioma victims have pursued a controversial legal maneuver referred to as a Texas Two-Step to evade legal liability. Now, in response to one of these attempts by Georgia-Pacific, a bipartisan group of U.S. senators — Dick Durbin (D-Illinois), Sheldon Whitehouse (D-Rhode Island), and Josh Hawley (R-Missouri) —
-
Court Allows Maine Widower’s Wrongful Death Case Against J&J to Proceed
Despite Johnson & Johnson and Pecos River Talc’s legal pleading, a federal court is allowing nearly all of widower Andrew Curtin’s mesothelioma wrongful death claim to proceed. His lawsuit blames the company for the death of his wife, Cynthia Cartwright, alleging that her lifelong use of J&J baby powder exposed her to asbestos.
-
Scientists Discover Drug Combination That Targets BAP1-Deficient Mesothelioma
Scientists have discovered a promising drug combination that shrinks tumors and prolongs survival in patients with mesothelioma and other cancers that contain BAP1 mutations. The treatment approach takes advantage of the fact that the genetic change makes the asbestos-related cancer’s deadly tumors less aggressive and more treatable than those without the mutation.
-
Study Shows Peritoneal Mesothelioma Microenvironment Creates Poor Immunotherapy Response
Australian researchers have discovered that peritoneal mesothelioma develops in an immune-suppressive tumor microenvironment that makes it resistant to checkpoint immunotherapy. These findings explain the significant difference between pleural mesothelioma and peritoneal mesothelioma patients observed in clinical trials.
-
Memorial Sloan Kettering Study Reports Increase in Mesothelioma in Younger, Female Patients
A just-released study from researchers at New York’s Memorial Sloan Kettering Cancer Center has revealed an alarming trend of diagnoses in patients under age 50, particularly among younger women with no self-reported history of asbestos exposure. The study’s authors urge physicians to familiarize themselves with the symptoms of the rare form of cancer and consider
-
Study Confirms Importance of Low-Dose CT Lung Screening for Mesothelioma and Other Cancers
A recent study of low-dose CT lung cancer screening results reinforces the technology’s importance for screening those at risk of mesothelioma. Researchers from Brown University found that the protocol has detected “significant incidental findings” linked to increased risk of extrapulmonary cancer diagnoses—including cancers affecting the pleura.
-
1977 Talc Safety Article Retracted After Author is Linked to Johnson & Johnson
In a move that is sure to have significant implications for mesothelioma and ovarian cancer litigation, one of the world’s most prestigious medical journals has retracted a 49-year-old unsigned commentary on cosmetic talc safety. The Lancet announced the action after the article’s author was discovered to be a paid Johnson & Johnson consultant.
-
Jury Awards $33.4 Million to Mesothelioma Victim Sickened by Lighting Equipment
A Los Angeles County Superior Court jury has awarded over $33 million in non-economic damages to an 80-year-old U.S. Army veteran who blamed exposure to asbestos-containing theatrical lighting equipment for his diagnosis with pleural mesothelioma. The jury found the company 100% liable and guilty of malice.
-
Jury Orders Shipyard to Pay $6.6 Million to Mesothelioma Victim’s Survivors
In Louisiana, an Orleans Parish jury has awarded $6.625 million in damages to the family of a former Avondale Shipyards clerk who died from mesothelioma. The group took just 80 minutes to find that Ronald Marcella’s fatal illness was caused by exposure he experienced at the shipyard from 1962 to 1964.
-
Japan Approves Workers’ Compensation for Mesothelioma Death of Cosmetics Salesclerk
In a case highlighting the global problem of asbestos contamination in talc products, the Sendai Labor Standards Inspection Office in Japan has approved workers’ compensation following the mesothelioma death of a 68-year-old former Shiseido Co. salesclerk. The group ruled that she likely developed the rare form of cancer from having been exposed to contaminated cosmetics
-
Talc Company Fails in Attempt to Dismiss Mesothelioma Lawsuit
After Stuart Linde died of mesothelioma in 2023, his estate sued Bristol Myers Squibb (BMS), blaming the company’s Ammens talc powder for his fatal illness. While the pharmaceutical giant filed a petition to have the case dismissed, the New York Supreme Court denied its motion for summary judgment, finding that genuine issues of fact need
-
Harvard’s Post-Surgery Blood Clot Study Could Save Mesothelioma Patients’ Lives
Pleural mesothelioma surgery presents several risks, including a much higher risk of blood clots than in patients undergoing other surgeries. In a recent study, researchers from Harvard University identified biomarkers that could predict which mesothelioma patients face the highest risk. This discovery could reduce the current 11% mortality rate from post-operative venous thromboembolism (VTE) that
-
Kentucky Court Rules Workers’ Comp Doesn’t Bar Secondary Mesothelioma Claims
A groundbreaking ruling by the Kentucky Supreme Court made all the difference for the family of a woman who died of mesothelioma in 2017. Following nearly ten years of litigation, the court ruled that the state’s’ workers’ compensation exclusivity rule doesn’t prevent negligence and product liability claims stemming from “take-home” asbestos exposure.
